Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer.
Yokouchi H, Yamazaki K, Kinoshita I, Konishi J, Asahina H, Sukoh N, Harada M, Akie K, Ogura S, Ishida T, Munakata M, Dosaka-Akita H, Isobe H, Nishimura M.
Yokouchi H, et al. Among authors: kinoshita i.
BMC Cancer. 2007 Mar 20;7:51. doi: 10.1186/1471-2407-7-51.
BMC Cancer. 2007.
PMID: 17374153
Free PMC article.